Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio Free Cash Flow : -33.50M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.50M |
| March 31, 2026 | -30.65M |
| December 31, 2025 | -31.51M |
| September 30, 2025 | -33.49M |
| June 30, 2025 | -36.10M |
| March 31, 2025 | -42.91M |
| December 31, 2024 | -47.99M |
| September 30, 2024 | -59.06M |
| June 30, 2024 | -70.76M |
| March 31, 2024 | -74.87M |
| December 31, 2023 | -78.41M |
| September 30, 2023 | -83.38M |
| June 30, 2023 | -89.35M |
| March 31, 2023 | -99.02M |
| Date | Value |
|---|---|
| December 31, 2022 | -123.48M |
| September 30, 2022 | -137.08M |
| June 30, 2022 | -164.51M |
| March 31, 2022 | -167.44M |
| December 31, 2021 | -152.52M |
| September 30, 2021 | -145.16M |
| June 30, 2021 | -110.27M |
| March 31, 2021 | -92.24M |
| December 31, 2020 | -82.17M |
| September 30, 2020 | -68.95M |
| June 30, 2020 | -62.81M |
| March 31, 2020 | -62.44M |
| December 31, 2019 | -41.59M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ARS Pharmaceuticals, Inc. | -196.60M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.181M |
| Free Cash Flow Per Share (Quarterly) | -2.861 |
| Free Cash Flow to Equity (Quarterly) | -3.426M |
| Free Cash Flow to Firm (Quarterly) | -9.181M |
| Free Cash Flow Yield | -232.0% |